Device Week, 10 December 2020 – LivaNova Divests Valves; Experts Address ‘Metabesity’

In this week’s podcast: LivaNova sells its heart valve business to a private equity firm, an expert panel discusses the challenges of addressing so-called “metabesity,” and Dexcom explains its plans to double its revenue over the next few years. Listen to the podcast via the player below: Medtech Insight article addressing topics discussed in this episode: LivaNova Sells Surgical Heart Valve Business To Gyrus Capital For $73M Conquering Metabesity: Expert Panel Discusses Roadmap To Find Solutions Exec Chat: Dexcom CEO Kevin Sayer Talks About Access, Growth, Resiliency During Pandemic